SECURITY AGREEMENTSecurity Agreement • November 6th, 2015 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
This SECURITY AGREEMENT, dated as of July 28, 2015 (as the same may be supplemented, replaced or otherwise modified from time to time, this “Security Agreement”), is made by ARIAD PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and ARIAD PHARMA LTD. (“ARIAD UK”), a company organized under the laws of England with company number 06356675, in favor of PDL BIOPHARMA, INC., a Delaware corporation, as Purchaser (in such capacity, the “Purchaser”) under the Revenue Interest Assignment Agreement, dated as of July 28, 2015 (as amended, supplemented or otherwise modified from time to time, the “Assignment Agreement”) between the Company and the Purchaser.
REVENUE INTEREST ASSIGNMENT AGREEMENT Dated as of July 28, 2015 between ARIAD PHARMACEUTICALS, INC. and PDL BIOPHARMA, INC. Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and...Revenue Interest Assignment Agreement • November 6th, 2015 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
This REVENUE INTEREST ASSIGNMENT AGREEMENT (as amended, supplemented or otherwise modified from time to time, this “Agreement”) is made and entered into as of July 28, 2015, by and between ARIAD Pharmaceuticals, Inc., a Delaware corporation (“ARIAD” or the “Company”), and PDL BioPharma, Inc., a Delaware corporation (“Purchaser”).
SUBLEASE by and betweenRedacted Lease • November 6th, 2015 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
This Sublease (the “Sublease”) is made as of July 16, 2015 by and between ARIAD Pharmaceuticals, Inc., a Delaware corporation, having an address of 26 Landsdowne Street, Cambridge, MA 02139 (“Sublandlord”), and INTERNATIONAL BUSINESS MACHINES CORPORATION, a New York corporation, having an address of New Orchard Road, Armonk NY 10504 (“Subtenant”).
